Gilead Sciences Long Term Deferred Assets (Quarterly) Analysis

Gilead Sciences, Inc. (GILD)

124.31 -0.60 (-0.48%) USD | NASDAQ | Jan 20, 11:47

View Long Term Deferred Assets (Quarterly) for GILD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Johnson & Johnson	Upgrade
Eli Lilly & Co.	Upgrade
Merck & Co., Inc.	--
Regeneron Pharmaceuticals, Inc.	Upgrade